All statistical analyses were performed using R software (version 4.3.1
Obesity is a well-established risk factor for the development and progression of knee OA (KOA)
Protocol 1: the slow and steady semaglutide escalation Goal: Minimize side effects while reaching effective therapeutic levels Schedule: Weeks 1-6: 0.25 mg weekly (extended from standard 4 weeks) Weeks 7-12: 0.5 mg weekly (extended) Weeks 13-16: 1.0 mg weekly Weeks 17-20: 1.7 mg weekly Week 21+: 2.4 mg maintenance Why the plotter supports this: By extending the initial low-dose phases to six weeks instead of four, you ensure complete steady state establishment before escalation
Limitations : Do not promote true tissue healing Long-term side effects include nutrient malabsorption, dependency, and microbiome disruption BPC-157 advantage : Promotes healing at the root level restoring the epithelial lining and improving motility and blood flow Can be used to complement medical therapy , especially during flare recovery or post-surgery When to Use BPC-157 Consider adding BPC-157 to your gut healing protocol if: You're not improving with diet, probiotics, or supplements alone Youre recovering from gut injury, surgery, or NSAID-related damage You need faster healing for leaky gut, ulcers, or chronic inflammation Used correctly, BPC-157 bridges the gap between symptom management and true regenerative repair especially when combined with foundational gut health support like Probiotix and Collagen Protein
The compound is not yet approved as a pharmaceutical in Canada or the US, with FDA approval expected in 2026 to 2027
American Board of Obesity Medicine
